THY1 and liver cancer: To gain more insights into the tumorigenic capacity of CD90+ stem cells in liver cancer, the correlation of major SHH/Gli signalling components such as Gli1 and Gli3 with CD90 expression in multiple liver cancer cell lines and tissue samples was evaluated in this study.